195 related articles for article (PubMed ID: 26980676)
1. Stimulator of interferon genes (STING): A "new chapter" in virus-associated cancer research. Lessons from wild-derived mouse models of innate immunity.
Poltorak A; Kurmyshkina O; Volkova T
Cytokine Growth Factor Rev; 2016 Jun; 29():83-91. PubMed ID: 26980676
[TBL] [Abstract][Full Text] [Related]
2. Insights into the Role of Innate Immunity in Cervicovaginal Papillomavirus Infection from Studies Using Gene-Deficient Mice.
Scagnolari C; Cannella F; Pierangeli A; Mellinger Pilgrim R; Antonelli G; Rowley D; Wong M; Best S; Xing D; Roden RBS; Viscidi R
J Virol; 2020 Jun; 94(12):. PubMed ID: 32295905
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus polymerase disrupts K63-linked ubiquitination of STING to block innate cytosolic DNA-sensing pathways.
Liu Y; Li J; Chen J; Li Y; Wang W; Du X; Song W; Zhang W; Lin L; Yuan Z
J Virol; 2015 Feb; 89(4):2287-300. PubMed ID: 25505063
[TBL] [Abstract][Full Text] [Related]
4. TLR4: An Important Molecule Participating in Either Anti-Human Papillomavirus Immune Responses or Development of Its Related Cancers.
Bahramabadi R; Dabiri S; Iranpour M; Kazemi Arababadi M
Viral Immunol; 2019 Dec; 32(10):417-423. PubMed ID: 31721657
[TBL] [Abstract][Full Text] [Related]
5. The emerging roles of the STING adaptor protein in immunity and diseases.
Liu X; Wang C
Immunology; 2016 Mar; 147(3):285-91. PubMed ID: 26643733
[TBL] [Abstract][Full Text] [Related]
6. Activation of Stimulator of Interferon Genes (STING) and Sjögren Syndrome.
Papinska J; Bagavant H; Gmyrek GB; Sroka M; Tummala S; Fitzgerald KA; Deshmukh US
J Dent Res; 2018 Jul; 97(8):893-900. PubMed ID: 29505322
[TBL] [Abstract][Full Text] [Related]
7. Diminished Innate Antiviral Response to Adenovirus Vectors in cGAS/STING-Deficient Mice Minimally Impacts Adaptive Immunity.
Anghelina D; Lam E; Falck-Pedersen E
J Virol; 2016 Jul; 90(13):5915-27. PubMed ID: 27076643
[TBL] [Abstract][Full Text] [Related]
8. Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV
Dorta-Estremera S; Hegde VL; Slay RB; Sun R; Yanamandra AV; Nicholas C; Nookala S; Sierra G; Curran MA; Sastry KJ
J Immunother Cancer; 2019 Sep; 7(1):252. PubMed ID: 31533840
[TBL] [Abstract][Full Text] [Related]
9. Papillomavirus capsid mutation to escape dendritic cell-dependent innate immunity in cervical cancer.
Yang R; Wheeler CM; Chen X; Uematsu S; Takeda K; Akira S; Pastrana DV; Viscidi RP; Roden RB
J Virol; 2005 Jun; 79(11):6741-50. PubMed ID: 15890912
[TBL] [Abstract][Full Text] [Related]
10. Agonist of stimulator of interferon genes as antitumor agents: a patent review (2008-2020).
Chen NN; Zhang H; You QD; Xu XL
Expert Opin Ther Pat; 2021 Jun; 31(6):563-584. PubMed ID: 33459063
[TBL] [Abstract][Full Text] [Related]
11. STING-mediated DNA sensing in cancer immunotherapy.
Zhou X; Jiang Z
Sci China Life Sci; 2017 Jun; 60(6):563-574. PubMed ID: 28639100
[TBL] [Abstract][Full Text] [Related]
12. The cGas-Sting Signaling Pathway Is Required for the Innate Immune Response Against Ectromelia Virus.
Cheng WY; He XB; Jia HJ; Chen GH; Jin QW; Long ZL; Jing ZZ
Front Immunol; 2018; 9():1297. PubMed ID: 29963044
[TBL] [Abstract][Full Text] [Related]
13. The Emerging Roles of STING in Bacterial Infections.
Marinho FV; Benmerzoug S; Oliveira SC; Ryffel B; Quesniaux VFJ
Trends Microbiol; 2017 Nov; 25(11):906-918. PubMed ID: 28625530
[TBL] [Abstract][Full Text] [Related]
14. STING signalling: an emerging common pathway in autoimmunity and cancer.
McCaffary D
Immunopharmacol Immunotoxicol; 2017 Oct; 39(5):253-258. PubMed ID: 28724326
[TBL] [Abstract][Full Text] [Related]
15. STING-dependent cytosolic DNA sensing mediates innate immune recognition of immunogenic tumors.
Woo SR; Fuertes MB; Corrales L; Spranger S; Furdyna MJ; Leung MY; Duggan R; Wang Y; Barber GN; Fitzgerald KA; Alegre ML; Gajewski TF
Immunity; 2014 Nov; 41(5):830-42. PubMed ID: 25517615
[TBL] [Abstract][Full Text] [Related]
16. RIG-I-Mediated STING Upregulation Restricts Herpes Simplex Virus 1 Infection.
Liu Y; Goulet ML; Sze A; Hadj SB; Belgnaoui SM; Lababidi RR; Zheng C; Fritz JH; Olagnier D; Lin R
J Virol; 2016 Oct; 90(20):9406-19. PubMed ID: 27512060
[TBL] [Abstract][Full Text] [Related]
17. STING-dependent cytosolic DNA sensing pathways.
Barber GN
Trends Immunol; 2014 Feb; 35(2):88-93. PubMed ID: 24309426
[TBL] [Abstract][Full Text] [Related]
18. STING Signaling in Cancer Cells: Important or Not?
Sokolowska O; Nowis D
Arch Immunol Ther Exp (Warsz); 2018 Apr; 66(2):125-132. PubMed ID: 28748479
[TBL] [Abstract][Full Text] [Related]
19. Selective reactivation of STING signaling to target Merkel cell carcinoma.
Liu W; Kim GB; Krump NA; Zhou Y; Riley JL; You J
Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13730-13739. PubMed ID: 32482869
[TBL] [Abstract][Full Text] [Related]
20. Species-specific disruption of STING-dependent antiviral cellular defenses by the Zika virus NS2B3 protease.
Ding Q; Gaska JM; Douam F; Wei L; Kim D; Balev M; Heller B; Ploss A
Proc Natl Acad Sci U S A; 2018 Jul; 115(27):E6310-E6318. PubMed ID: 29915078
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
